Autoimmunity in common variable immunodeficiency

Current Allergy and Asthma Reports

Volumn 9, Issue 5, 2009, Pages 347-352

  Agarwal, Shradha ^b   Cunningham Rundles, Charlotte ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; B CELL ACTIVATING FACTOR RECEPTOR; BUDESONIDE; CD19 ANTIGEN; CORTICOSTEROID; FAS ANTIGEN; GENE PRODUCT; HLA DQ ANTIGEN; HLA DR ANTIGEN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR; MERCAPTOPURINE; PROTEIN MSH5; TRANSCRIPTION FACTOR FOXP3; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE HEPATITIS; AUTOIMMUNE NEUTROPENIA; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; COMMON VARIABLE IMMUNODEFICIENCY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DRUG MEGADOSE; ENTERITIS; GENE LOCUS; GENE MUTATION; GENETIC VARIABILITY; GRANULOMATOSIS; GRANULOMATOUS INFLAMMATION; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE DYSREGULATION; IMMUNOGLOBULIN DEFICIENCY; JUVENILE RHEUMATOID ARTHRITIS; LOW DRUG DOSE; LYMPHADENOPATHY; LYMPHOCYTE FUNCTION; PHENOTYPE; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SPLENOMEGALY; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGAMMAGLOBULINEMIA; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; COMMON VARIABLE IMMUNODEFICIENCY; CYTOKINES; DENDRITIC CELLS; HUMANS; T-LYMPHOCYTES;

EID: 68949148856     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-009-0051-0     Document Type: Review

References (50)

1. Geha RS, Notarangelo LD, Casanova JL, et al.: Primary immunodeficiency diseases: An update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007, 120:776-794.
2. Chapel H, Lucas M, Lee M, et al.: Common variable immunodeficiency disorders: Division into distinct clinical phenotypes. Blood 2008, 112:277-286.
3. Cunningham-Rundles C: Common variable immunodeficiency. Curr Allergy Asthma Rep 2001, 1:421-429.
4. Quinti I, Soresina A, Spadaro G, et al.: Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007, 27:308-316.
5. Cunningham-Rundles C, Bodian C: Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999, 92:34-48.
6. Wang J, Cunningham-Rundles C: Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 2005, 25:57-62.
7. Michel M, Chanet V, Galicier L, et al.: Autoimmune thrombocytopenic purpura and common variable immunodeficiency: Analysis of 21 cases and review of the literature. Medicine (Baltimore) 2004, 83:254-263.
8. Swierkot J, Lewandowicz-Uszynska A, Chelbicki A, et al.: Rheumatoid arthritis in a patient with common variable immunodeficiency: Difficulty in diagnosis and therapy. Clin Rheumatol 2006, 25:92-94.
9. Bloom KA, Chung D, Cunningham-Rundles C: Osteoarticular infectious complications in patients with primary immunodeficiencies. Curr Opin Rheumatol 2008, 20:480-485.
10. Fernandez-Castro M, Mellor-Pita S, Citores MJ, et al.: Common variable immunodeficiency in systemic lupus erythematosus. Semin Arthritis Rheum 2007, 36:238-245.
11. Yong PF, Aslam L, Karim MY, et al.: Management of hypogammaglobulinaemia occurring in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2008, 47:1400-1405.
12. Mechanic LJ, Dikman S, Cunningham-Rundles C: Granulomatous disease in common variable immunodeficiency. Ann Intern Med 1997, 127:613-617.
13. Morimoto Y, Routes JM: Granulomatous disease in common variable immunodeficiency. Curr Allergy Asthma Rep 2005, 5:370-375.
14. Mullighan CG, Fanning GC, Chapel HM, et al.: TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: Role in the pathogenesis of granulomatous disease. J Immunol 1997, 159:6236-6241.
15. Aukrust P, Lien E, Kristoffersen AK, et al.: Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency-possible immunologic and clinical consequences. Blood 1996, 87:674-681.
16. Kalia S, Dutz JP: New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther 2007, 20:160-174.
17. Daniels JA, Lederman HM, Maitra A, et al.: Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): A clinicopathologic study and review. Am J Surg Pathol 2007, 31:1800-1812.
18. Daniels JA, Torbenson M, Vivekanandan P, et al.: Hepatitis in common variable immunodeficiency. Hum Pathol 2009, 40:484-488.
19. Bryant A, Calver NC, Toubi E, et al.: Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin Immunol Immunopathol 1990, 56:239-248.
20. Cunningham-Rundles C, Radigan L, Knight AK, et al.: TLR9 activation is defective in common variable immune deficiency. J Immunol 2006, 176:1978-1987.
21. Eisenstein EM, Chua K, Strober W, et al.: B cell differentiation defects in common variable immunodeficiency are ameliorated after stimulation with anti-CD40 antibody and IL-10. J Immunol 1994, 152:5957-5968.
22. Bonhomme D, Hammarstrom L, Webster D, et al.: Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J Immunol 2000, 165:4725-4730.
23. Warnatz K, Denz A, Drager R, et al.: Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: A new approach to classify a heterogeneous disease. Blood 2002, 99:1544-1551.
24. Wehr C, KiviojaDT, Schmitt C, et al.: The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008, 111:77-85.
25. Alachkar H, Taubenheim N, Haeney MR, et al.: Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency. Clin Immunol 2006, 120:310-318.
26. Ko J, Radigan L, Cunningham-Rundles C: Immune competence and switched memory B cells in common variable immunodeficiency. Clin Immunol 2005, 116:37-41.
27. Sanchez-Ramon S., Radigan L, Yu JE, et al.: Memory B cells in common variable immunodeficiency: Clinical associations and sex differences. Clin Immunol 2008, 128:314-321.
28. Mackay F, Silveira PA, Brink R: B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr Opin Immunol 2007, 19:327-336.
29. Knight AK, Radigan L, Marron T, et al.: High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency. Clin Immunol 2007, 124:182-189.
30. Genre J, Errante PR, Kokron CM, et al.: Reduced frequency of CD4(+) CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with common variable immunodeficiency: A link to autoimmunity? Clin Immunol 2009 Apr 23 (Epub ahead of print).
31. Yu GP, Chiang D, Song SJ, et al.: Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease. Clin Immunol 2009, 131:240-253.
32. Vorechovsky I, Zetterquist H, Paganelli R, et al.: Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin Immunol Immunopathol 1995, 77:185-192.
33. Schaffer AA, Salzer U, Hammarstrom L, et al.: Deconstructing common variable immunodeficiency by genetic analysis. Curr Opin Genet Dev 2007, 17:201-212.
34. Sekine H, Ferreira RC, Pan-Hammarstrom Q, et al.: Role for Msh5 in the regulation of Ig class switch recombination. Proc Natl Acad Sci U S A 2007, 104:7193-7198.
35. Grimbacher B, Hutloff A, Schlesier M, et al.: Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003, 4:261-268.
36. van Zelm MC, Reisli I, van der Burg M, et al.: An antibodydeficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006, 354:1901-1912.
37. Goldacker S, Warnatz K: Tackling the heterogeneity of CVID. Curr Opin Allergy Clin Immunol 2005, 5:504-509.
38. Castigli E, Wilson SA, Garibyan L, et al.: TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005, 37:829-834.
39. Salzer U, Chapel HM, Webster AD, et al.: Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005, 37:820-828.
40. Pan-Hammarstrom Q, Salzer U, Du L, et al.: Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 2007, 39:429-430.
41. Zhang L, Radigan L, Salzer U, et al.: Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: Clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol 2007, 120:1178-1185.
42. Salzer U, Bacchelli C, Buckridge S, et al.: Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 2009, 113:1967-1976.
43. Warnatz K, Wehr C, Drager R, et al.: Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. Immunobiology 2002, 206:502-513.
44. Yong PF, Workman S, Wahid F, et al.: Selective deficits in blood dendritic cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia but not specific polysaccharide antibody deficiency. Clin Immunol 2008, 127:34-42.
45. Giovannetti A, Pierdominici M, Mazzetta F, et al.: Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 2007, 178:3932-3943.
46. Cunningham-Rundles C, Radigan L: Deficient IL-12 and dendritic cell function in common variable immune deficiency. Clin Immunol 2005, 115:147-153.
47. Sneller MC: Common variable immunodeficiency. Am J Med Sci 2001, 321:42-48.
48. Holm AM, Aukrust P, Damas JK, et al.: Abnormal interleukin-7 function in common variable immunodeficiency. Blood 2005, 105:2887-2890.
49. Rezaei N, Amirzagar AA, Shakiba Y, et al.: Proinflammatory cytokine gene single nucleotide polymorphisms in common variable immunodeficiency. Clin Exp Immunol 2009, 155:21-27.
50. Eisenstein EM, Jaffe JS, Strober W: Reduced interleukin-2 (IL-2) production in common variable immunodeficiency is due to a primary abnormality of CD4+ T cell differentiation. J Clin Immunol 1993, 13:247-258.